Israel Englander Kodiak Sciences Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Millennium Management LLC holds 12,757 shares of KOD stock, worth $33,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,757

Previous 218,839 94.17%

Holding current value

$33,678

Previous $1.15 Million 97.48%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $471,927 - $923,247	-206,082 Reduced 94.17%	12,757 $29,000
Q1 2024 May 15, 2024	SELL	$3.01 - $7.45 $944,522 - $2.34 Million	-313,795 Reduced 58.91%	218,839 $1.15 Million
Q4 2023 Feb 14, 2024	SELL	$1.4 - $3.24 $945,064 - $2.19 Million	-675,046 Reduced 55.9%	532,634 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $935,073 - $2.06 Million	217,459 Added 21.96%	1,207,680 $8.33 Million
Q1 2023 May 15, 2023	BUY	$4.81 - $8.88 $2.85 Million - $5.26 Million	591,842 Added 148.56%	990,221 $6.14 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $2.52 Million - $3.11 Million	-385,771 Reduced 49.2%	398,379 $2.85 Million
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $2.21 Million - $3.65 Million	291,767 Added 59.26%	784,150 $6.07 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $2.84 Million - $5.34 Million	-563,347 Reduced 53.36%	492,383 $3.76 Million
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $7.4 Million - $93.4 Million	1,043,961 Added 8870.43%	1,055,730 $8.15 Million
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $127,985 - $203,399	-1,583 Reduced 11.86%	11,769 $998,000
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $4.31 Million - $5.62 Million	-52,533 Reduced 79.73%	13,352 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $3.92 Million - $6.42 Million	50,717 Added 334.37%	65,885 $6.13 Million
Q1 2021 May 17, 2021	SELL	$110.45 - $164.47 $1.34 Million - $2 Million	-12,131 Reduced 44.44%	15,168 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $268,829 - $681,274	4,423 Added 19.33%	27,299 $4.01 Million
Q3 2020 Nov 16, 2020	SELL	$45.05 - $59.27 $4.33 Million - $5.7 Million	-96,110 Reduced 80.77%	22,876 $1.35 Million
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $3.9 Million - $6.05 Million	-91,270 Reduced 43.41%	118,986 $6.44 Million
Q1 2020 May 14, 2020	BUY	$38.18 - $73.95 $132,408 - $256,458	3,468 Added 1.68%	210,256 $10 Million
Q4 2019 Feb 14, 2020	BUY	$13.9 - $76.65 $2.87 Million - $15.9 Million	206,788 New	206,788 $14.9 Million
Q3 2019 Nov 14, 2019	SELL	$10.24 - $17.57 $135,761 - $232,943	-13,258 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$6.2 - $12.0 $98,859 - $191,340	-15,945 Reduced 54.6%	13,258 $155,000
Q2 2019 Aug 14, 2019	BUY	$6.2 - $12.0 $181,058 - $350,436	29,203 New	29,203 $80,000

Others Institutions Holding KOD

# of Institutions

104

Shares Held

39.8M

Call Options Held

7.6K

Put Options Held

3.5K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $137M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account